IDM’s and Epimmune’s Merger Highlights Biotech Funding Difficulties
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 59 (Table of Contents)
Published: 5 May-2005
DOI: 10.3833/pdr.v2005.i59.690 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Immuno-Designed Molecules entered into merger agreement with Epimmune to form a combined company to be named as IDM, Inc...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS